LINE

Text:AAAPrint
Society

China approves world's first long-acting anti-HIV drug

1
2018-06-05 15:54:58Global Times Editor : Li Yan ECNS App Download

The China Food and Drug Administration approved the domestically developed, long-acting injectable HIV drug Albuvirtide.

It is the world's first long-acting intravenous treatment for HIV, the Science and Technology Daily reported on Tuesday.

Developed by the Nanjing-based Frontier Biotechnologies Inc, the drug can block the fusion of the viral and host cell membranes, interrupting the HIV life cycle in its earliest stage, the Xinhua News Agency reported.

The drug is a fusion inhibitor that should be used with antiretroviral drugs to treat people suffering from HIV who have received antiviral therapy.

"China's first domestically developed drug offers new HIV patients a new treatment option. We hope to dispel the fact that China has not developed good anti-HIV medicine," Xie Dong, chief scientist and former head of Frontier Biotechnologies Inc, said.

Data show 718,270 people suffer from HIV/AIDS in China.  As of the end of June 2017, 221,628 people had died of AIDS-related diseases in China, Xinhua reported in December 2017.

  

Related news

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

News
Politics
Business
Society
Culture
Military
Sci-tech
Entertainment
Sports
Odd
Features
Biz
Economy
Travel
Travel News
Travel Types
Events
Food
Hotel
Bar & Club
Architecture
Gallery
Photo
CNS Photo
Video
Video
Learning Chinese
Learn About China
Social Chinese
Business Chinese
Buzz Words
Bilingual
Resources
ECNS Wire
Special Coverage
Infographics
Voices
LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2018 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.